Suppr超能文献

印度南部一家三级护理医院的 COVID-19 的肾脏表现及其与疾病严重程度的关系:一项回顾性研究。

Renal manifestations of Covid-19 and its association with severity of disease in a tertiary care hospital of south India- A retrospective study.

机构信息

Ms Ramiah Medical College & Hospital, Bangalore.

出版信息

J Assoc Physicians India. 2022 Apr;70(4):11-12.

Abstract

UNLABELLED

Renal involvement in patients with COVID-19 ranges from proteinuria and hematuria to acute kidney injury (AKI). The occurrence of AKI range from 0.5% to 80% across various studies. Our study was conducted to know the renal manifestations of COVID-19 in south Indian population and its association with severity.

MATERIAL

The study assessed COVID-19 positive adult patients admitted from 1/9/2020 to 31/10/2020. Data was collected by accessing electronic medical records of patients. Proteinuria and hematuria were assessed by urine dipstick. Lab data including S. Creatinine at admission was accessed. S. Creatinine at a mean duration of 7±2, 14±4 days during hospitalization and on follow-up at a mean duration of 45 days after discharge was also captured.

OBSERVATION

A total of 1561 patients admitted during the study period were screened. After the exclusion criteria, 426 patients admitted with COVID-19 infection were enrolled. The occurrence of AKI was 14.8%. Proteinuria was positive in 75 patients (17.6%) hematuria in 39 patients (9.15 %). Patients with AKI, proteinuria and/or hematuria were more likely to have severe COVID-19 illness. 47.5% patients with AKI, 45.9 % with proteinuria and 34.4 % with hematuria had severe COVID-19 illness. The recovery of AKI at a mean duration of 45±15 days post discharge was 83.63 %.

CONCLUSION

Renal involvement is not uncommon in patients with COVID-19 infection especially in patients with severe illness. Presence of AKI, proteinuria and/or hematuria is associated with increased mortality among patients hospitalized with COVID-19 infection.

摘要

未加说明

在 COVID-19 患者中,肾脏受累的范围从蛋白尿和血尿到急性肾损伤(AKI)。在不同的研究中,AKI 的发生率从 0.5%到 80%不等。我们的研究旨在了解南印度人群 COVID-19 的肾脏表现及其与严重程度的关系。

材料

这项研究评估了 2020 年 9 月 1 日至 10 月 31 日期间住院的 COVID-19 阳性成年患者。通过访问患者的电子病历来收集数据。蛋白尿和血尿通过尿试纸进行评估。还获取了入院时的 S. 肌酐、住院期间平均 7±2 天和 14±4 天以及出院后平均 45 天的 S. 肌酐实验室数据。

观察

在研究期间,共筛查了 1561 名患者。排除标准后,共纳入 426 名因 COVID-19 感染住院的患者。AKI 的发生率为 14.8%。75 名患者(17.6%)蛋白尿阳性,39 名患者(9.15%)血尿阳性。有 AKI、蛋白尿和/或血尿的患者更有可能患有严重的 COVID-19 疾病。47.5%的 AKI 患者、45.9%的蛋白尿患者和 34.4%的血尿患者患有严重的 COVID-19 疾病。出院后平均 45±15 天 AKI 的恢复率为 83.63%。

结论

COVID-19 感染患者的肾脏受累并不少见,尤其是在病情严重的患者中。AKI、蛋白尿和/或血尿的存在与 COVID-19 感染住院患者的死亡率增加有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验